Lilly, Novo Nordisk back direct-to-employer programs to expand access to weight-loss drugs

Eli Lilly said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access ...
Fierce Healthcare

Eli Lilly unveils new direct-to-employer model for weight loss drugs

Drugmaker Eli Lilly is rolling out a new model to make it easier for employers to provide access to its GLP-1 drugs for ...

Novo, Lilly said to sell obesity drugs directly to employers, bypassing PBMs

Novo Nordisk (NVO) and Eli Lilly (LLY) stocks are in focus as the duo plan to launch direct sales of weight loss drugs to ...
pharmaphorum

Waltz dances into direct-to-employer sales of obesity drugs

The direct-to-employer (DTE) is an industry first for FDA-approved weight-loss drugs like Novo Nordisk's Wegovy (semaglutide) ...

Brooks Nader admits her struggle with ‘self-confidence’ led her to use weight loss drugs

Brooks Nader admitted that her struggle with “self-confidence” led her to use weight loss drugs. “I’m still working on my ...
WGNO

Skye Bioscience Demonstrates Over 30% Weight Loss with Nimacimab and Tirzepatide Combination in Preclinical Model

Nimacimab shows comparable weight loss to monlunabant and tirzepatide alone, and an additive effect in combination with tirzepatide, in diet-induced obesity model New in vitro data demonstrates ...